• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西南部一家参考癌症中心中接受 I 期至 III 期子宫内膜癌治疗患者的生存及预后因素

Survival and prognostic factors of patients treated for Stage I to Stage III endometrial carcinoma in a reference cancer center in Southern Brazil.

作者信息

Pessini S A, Zettler C G, Wender M C O, Pellanda L C, Silveira G P G

机构信息

Department of Gynecology and Obstetrics, Federal Faculty Foundation of Medical Sciences, Porto Alegre, Brazil.

出版信息

Eur J Gynaecol Oncol. 2007;28(1):48-50.

PMID:17375707
Abstract

PURPOSE

To describe two- and five-year survival of patients with Stage I to III endometrial carcinoma and to identify prognostic factors.

STUDY DESIGN

Concurrent cohort study.

PATIENTS AND METHODS

Seventy-two patients were operated on by the same surgeon and followed up for at least two years. All the histopathological examinations were performed by the same pathologist. Survival was analyzed by the Kaplan-Meier method. Age, body mass index, tumor grade, myometrial invasion, histological type and stage were correlated with death.

RESULTS

Overall survival at two and five years was 90.2% and 81.4%, respectively. By bivariate analysis, FIGO stage, myometrial invasion, tumor grade, histology, adnexal and/or lymph node metastasis and age were significant predictors of death (p < 0.05). Multivariate analysis revealed significant associations with death: FIGO Stage III (p = 0.001), histological type other than endometrioid (p = 0.027) and age 70 or more (p = 0.04).

CONCLUSION

Endometrial carcinoma Stage III patients, histological types other than endometrioid and age 70 years or more are at significant risk for death.

摘要

目的

描述Ⅰ至Ⅲ期子宫内膜癌患者的两年和五年生存率,并确定预后因素。

研究设计

同期队列研究。

患者与方法

72例患者由同一位外科医生进行手术,并随访至少两年。所有组织病理学检查均由同一位病理学家进行。采用Kaplan-Meier法分析生存率。将年龄、体重指数、肿瘤分级、肌层浸润、组织学类型和分期与死亡情况进行相关性分析。

结果

两年和五年的总生存率分别为90.2%和81.4%。通过双变量分析,国际妇产科联盟(FIGO)分期、肌层浸润、肿瘤分级、组织学、附件和/或淋巴结转移以及年龄是死亡的显著预测因素(p < 0.05)。多变量分析显示与死亡有显著关联的因素为:FIGOⅢ期(p = 0.001)、非子宫内膜样组织学类型(p = 0.027)以及年龄70岁及以上(p = 0.04)。

结论

子宫内膜癌Ⅲ期患者、非子宫内膜样组织学类型患者以及70岁及以上患者死亡风险显著。

相似文献

1
Survival and prognostic factors of patients treated for Stage I to Stage III endometrial carcinoma in a reference cancer center in Southern Brazil.巴西南部一家参考癌症中心中接受 I 期至 III 期子宫内膜癌治疗患者的生存及预后因素
Eur J Gynaecol Oncol. 2007;28(1):48-50.
2
The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.与子宫内膜样癌相比,I-II期经临床和手术分期的浆液性乳头状和透明细胞子宫内膜癌的结局。
Gynecol Oncol. 2000 Apr;77(1):55-65. doi: 10.1006/gyno.2000.5737.
3
[Clinical application of adult comorbidity evaluation-27 in endometrial cancer].成人合并症评估-27在子宫内膜癌中的临床应用
Zhonghua Fu Chan Ke Za Zhi. 2016 Nov 25;51(11):810-817. doi: 10.3760/cma.j.issn.0529-567X.2016.11.003.
4
An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.强化随访不会改变临床I期子宫内膜癌患者的生存率。
Anticancer Res. 2000 May-Jun;20(3B):1977-84.
5
Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article).手术及病理分期为IIIA-IVB期的纯子宫内膜样型子宫内膜癌患者的预后:一项台湾妇科肿瘤学组(TGOG-2005)回顾性队列研究(一篇符合STROBE标准的文章)
Medicine (Baltimore). 2016 Apr;95(15):e3330. doi: 10.1097/MD.0000000000003330.
6
[Multivariate analysis of prognostic factors in endometrial carcinoma].[子宫内膜癌预后因素的多变量分析]
Ai Zheng. 2004 Sep;23(9):1085-8.
7
[Prognostic parameters in FIGO stage I endometrial carcinoma of endometrioid type].[国际妇产科联盟(FIGO)I期子宫内膜样型子宫内膜癌的预后参数]
Vojnosanit Pregl. 2006 Dec;63(12):1006-10. doi: 10.2298/vsp0612006s.
8
[Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].同步原发性子宫内膜癌和卵巢癌的临床病理及生存分析
Zhonghua Fu Chan Ke Za Zhi. 2018 Dec 25;53(12):816-822. doi: 10.3760/cma.j.issn.0529-567x.2018.12.004.
9
[Clinical implications of positive peritoneal cytology in endometrial cancer].[子宫内膜癌中阳性腹膜细胞学检查的临床意义]
Zhonghua Fu Chan Ke Za Zhi. 2011 Aug;46(8):595-9.
10
Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.重新定义 I 期子宫内膜癌:纳入组织学、二元分级系统、肌层浸润和淋巴结评估。
Int J Gynecol Cancer. 2013 Nov;23(9):1620-8. doi: 10.1097/IGC.0b013e3182a5055e.

引用本文的文献

1
Postoperative radiotherapy for endometrial cancer.子宫内膜癌的术后放疗
Radiat Oncol J. 2012 Sep;30(3):108-16. doi: 10.3857/roj.2012.30.3.108. Epub 2012 Sep 30.
2
Long-term survival of endometrioid endometrial cancer patients.子宫内膜样型子宫内膜癌患者的长期生存情况。
Arch Med Sci. 2010 Dec;6(6):937-44. doi: 10.5114/aoms.2010.19305. Epub 2010 Dec 29.